Clinical Trials Support Services Market Size to Reach USD 48.5 billion, at a 8.1 % CAGR By 2033 - Transparency Market Research, Inc.
17 janv. 2024 10h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global clinical trials support services market is estimated to flourish at a CAGR of...
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
16 janv. 2024 07h30 HE
|
Ocugen
MALVERN, Pa., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Biopharmaceutical Market Size Worth USD 1651.4 Billion in 2032 | Emergen Research
15 janv. 2024 11h00 HE
|
Emergen Research
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global biopharmaceutical market size was USD 411.4 Billion in 2022 and is expected to register a rapid revenue CAGR of 15.2% during the forecast...
PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index
12 janv. 2024 11h42 HE
|
PRISM MarketView
PRISM MarketView Announces the Addition of Verastem to Emerging Women’s Health Index
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
09 janv. 2024 10h25 HE
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
21 déc. 2023 16h00 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option Closes acquisition of...
Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innovation Fund and ARTIS Ventures
19 déc. 2023 09h00 HE
|
Unnatural Products
Santa Cruz, CA, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with chemistry to usher in the next generation of molecularly targeted therapeutics,...
Biopharmaceutical CMO Market Size, Share & Growth Analysis, [2028] | With CAGR of 12.6%
19 déc. 2023 05h46 HE
|
Fortune Business Insights
Pune, India, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The Biopharmaceutical CMO Market size was expected to be worth USD 11.56 billion in 2021 and projected to reach USD 26.49 billion by 2028, recording a...
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
14 déc. 2023 07h05 HE
|
Clearside Biomedical, Inc.
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to Tolimidone, a Phase II Ready Asset for Type 1 Diabetes
27 nov. 2023 09h00 HE
|
Biodexa Pharmaceuticals PLC
Cardiff , Nov. 27, 2023 (GLOBE NEWSWIRE) -- 27 November 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to...